Imatinib Not Yet Recruiting Phase 2 Trials for Cervical Spinal Cord Injury Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02363361Treatment of Cervical Spinal Cord Injury With Imatinib - a Safety and Feasibility Study